DNTH

Conviction 90HealthcareScan · Mon, Aug 10, 2026

DNTH$111.72+2.57%

ResistanceSupportVol 14Insider sell

Vol MA14 870.14K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Dianthus Therapeutics, Inc. /DE/PHARMACEUTICAL PREPARATIONSwww.dianthustx.com ↗

Price111.72

Change+2.57%

Gap-0.50%

Rel volume1.51×

Avg volume892.77K

Avg $ vol94.04M

SMA 20105.48

SMA 5095.27

SMA 20068.87

Price vs 50+17.27%

Price vs 200+62.22%

MA stackbullish

50/200 cross—

Supertrendup · 92.75

RSI (14)61

MACD hist0.07

MACD crossbull · 7d

Stoch %K / %D81 / 70

ADX (14)21

+DI / −DI22 / 11

RSI divergence—

MACD divergence—

ATR %+5.29%

ADR %5.76%

52w high112.64

52w low18.76

From 52w high-0.82%

Above 52w low+495.52%

New 52w highNo

SqueezeOff

Bollinger width16.90%

%B0.85

Donchian pos87.98%

Donchian high114.55

Donchian low91.01

AVWAP (52w high)109.39

vs AVWAP high+2.13%

AVWAP (52w low)65.33

vs AVWAP low+71.00%

OBV trendFlat

Chaikin MF (20)0.14

Today vs 20d1.51×

Avg vol (14d)870.14K

Avg vol (20d)892.77K

Avg $ vol (20d)94.04M

Market cap6.25B

RS 3m (vs SPY)+21.74%

RS 6m (vs SPY)+119.72%

RS line new highNo

Trend template8/8

Technical rank89.5

1 week+5.38%

1 month+14.47%

3 months+28.84%

6 months+120.14%

1 year+483.39%

YTD+181.55%

P/E-38.49

P/B5.33

P/S—

P/FCF-48.30

EPS-4.20

Div yield—

ROE-13.85%

ROA-13.38%

Debt/Eq—

Current26.10

EV/EBITDA-34.88

Gross margin—

Net margin—

Rev growth-67.35%

EPS growth-91.05%

Price target141.40

Target upside26.57%

Analyst ratingBuy

Institutional122.74%

Ent. value6.14B

Revenue396K

Net income-50.22M

Gross profit—

Free cash flow-129.37M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out54.67M

Employees92

ListedTue, Sep 12, 2023

Free float50.43M

Float %92.6%

Short interest9.22M

Days to cover8.9d

Short volume54.3%

Squeeze score79 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.90 vs −$0.93

Last surprise+3.2% beat

Setup gradeA+

Conviction90 / 100

Pattern quality—

Tech rank89.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance114.35

Support89.21

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DNTH

All disclosures →

No recent disclosed trades by Congress in DNTH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DNTH · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	800	$89K	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	104.09K	$11M	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Exercise	40K	$338K	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Exercise	126K	$1.1M	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	10.38K	$1.1M	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	23.91K	$2.6M	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	2.37K	$259K	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	2.54K	$279K	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Common Stock · 2026-08-07	Sell	21.91K	$2.4M	2026-08-07	2026-08-07
Garcia Marino CEO AND PRESIDENT · Stock Option (Right to Buy) · 2026-08-07	Exercise	40K	—	2026-08-07	2026-08-07

SEC filings

EDGAR filings in DNTH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.